Method for treating fibrotic diseases or other indications IC
申请人:Alteon, Inc.
公开号:US20020068729A1
公开(公告)日:2002-06-06
Provided, among other things, is a method of treating or ameliorating or preventing an indication of the invention in an animal, including a human comprising administering an effective amount of a compound of the formula I:
1
提供了一种处理、改善或预防动物包括人类发明的指示的方法,包括给予公式I的化合物的有效量:1
Stereochemical Study on 1,3-Dipolar Cycloaddition Reactions of Heteroaromatic<i>N</i>-Ylides with Symmetrically Substituted cis and trans Olefins
作者:Otohiko Tsuge、Shuji Kanemasa、Shigeori Takenaka
DOI:10.1246/bcsj.58.3137
日期:1985.11
Stereochemistry of the cycloadditions of twenty-four heteroaromatic N-ylides with several symmetrically substituted cis and trans olefins has been investigated. Cyclic and acyclic cis olefins cycloadd to the and form of the ylides in a highly endo-selective manner giving almost quantitative yields of stereospecific endo 3+2 cycloadducts. N-Ylides stabilized with a substituent of carbonyl type react
Benzothiazolium N-phenacylide reacted with methylenecyclopropenes having an acyl group on the 4-position to give 3a,11a-dihydro-5aH-furo[3′,2′:2,3]pyrido[6,1-b]benzothiazole derivative via an intermediary 3-butadienylbenzothiazolium betaine. The reaction of the ylide with a methylenecyclopropene bearing two cyano groups on the 4-position in THF gave a cyclobutane together with benzothiazole, whereas
Developing potential agents against atherosclerosis: Design, synthesis and pharmacological evaluation of novel dual inhibitors of oxidative stress and Squalene Synthase activity
作者:Maria G. Katselou、Alexios N. Matralis、Angeliki P. Kourounakis
DOI:10.1016/j.ejmech.2017.06.042
日期:2017.9
present the design, synthesis and pharmacological evaluation of novel dual-acting molecules as a therapeutic approach for atherosclerosis. Analogues 1–10 were rationally designed through structural modifications of their parent compounds (A-E) in order for structure-activity relationship studies to be carried out. Most compounds showed a significant inhibition against SqualeneSynthase activity exhibiting
The invention relates to a method of removing 3-deoxyglucosone and other alpha-dicarbonyl sugars from skin. The invention further relates to methods of inhibiting production and function of 3-deoxyglucosone and other alpha-dicarbonyl sugars in skin. The invention also relates to methods of treating 3-deoxyglucosone and other alpha-dicarbonyl sugars associated diseases and disorders of skin.